Dr. Mary M. Kemeny
Claim this profileQueens Hospital Center
Studies Cancer
Studies Tumors
4 reported clinical trials
8 drugs studied
Area of expertise
1Cancer
HER2 positive
ER positive
ER negative
2Tumors
Stage IV
Affiliated Hospitals
Clinical Trials Mary M. Kemeny is currently running
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Olanzapine vs Megestrol Acetate
for Cancer-Related Anorexia
This trial tests whether olanzapine or megestrol acetate is better at increasing appetite in patients with advanced cancer. These patients often struggle with eating and weight loss. Both medications aim to make them feel hungrier, helping them eat more and gain weight. Megestrol acetate is known for its effectiveness in increasing appetite in patients with cancer.
Recruiting2 awards Phase 31 criteria
More about Mary M. Kemeny
Clinical Trial Related3 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Mary M. Kemeny has experience with
- Questionnaire Administration
- Biospecimen Collection
- Data Collection
- Quality-of-Life Assessment
- Trastuzumab Emtansine
- Tucatinib
Breakdown of trials Mary M. Kemeny has run
Cancer
Tumors
Breast Cancer
Blood Cancers
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mary M. Kemeny specialize in?
Mary M. Kemeny focuses on Cancer and Tumors. In particular, much of their work with Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Mary M. Kemeny currently recruiting for clinical trials?
Yes, Mary M. Kemeny is currently recruiting for 2 clinical trials in Jamaica New York. If you're interested in participating, you should apply.
Are there any treatments that Mary M. Kemeny has studied deeply?
Yes, Mary M. Kemeny has studied treatments such as Questionnaire Administration, Biospecimen Collection, Data Collection.
What is the best way to schedule an appointment with Mary M. Kemeny?
Apply for one of the trials that Mary M. Kemeny is conducting.
What is the office address of Mary M. Kemeny?
The office of Mary M. Kemeny is located at: Queens Hospital Center, Jamaica, New York 11432 United States. This is the address for their practice at the Queens Hospital Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.